The Column Group Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 7
Professionals
  • Investments
  • 87
  • Portfolio
  • 22
  • Exits
  • 23
Exits

The Column Group General Information

Description

Founded in 2007, The Column Group is a venture capital investment firm based in San Francisco, California. The firm prefers to invest in early-stage drug discovery companies based on their unique scientific platforms and the potential to deliver multiple breakthrough therapeutics.

Contact Information

Year Founded
2007
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 1 Letterman Drive
  • Building D, Suite DM-900
  • San Francisco, CA 94129
  • United States
+1 (415) 000-0000

The Column Group Investments (87)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Eikon Therapeutics 05-May-2021 Early Stage VC 00000 Drug Discovery Generating Revenue 0000 0000 00.0
00000000 15-Apr-2021 0000 00000 Drug Discovery Pre-Clinical Trials 00000 0000000 00.0
000000 00000000000 01-Mar-2021 00000 00000 00000 Drug Discovery Generating Revenue 00000 0000000 00.0
0000000 21-Jan-2021 00000 00000 0000 Drug Discovery Generating Revenue 0000000 0000000 00.0
00000 000000000000 08-Dec-2020 00000 00000 0000 Drug Discovery Startup
00 000000000000000 30-Sep-2020 00000 00000 000.00 Drug Discovery Startup 00000 0000000 00.0
000000 00000000000 30-Sep-2020 00000 00000 000.00 Drug Discovery Clinical Trials - General 00000 0000000000
0000000000 17-Sep-2020 00000 00000 0000 Drug Discovery Pre-Clinical Trials 0000000 0000000 00.0
Hexagon Bio 15-Sep-2020 Early Stage VC 0000 Other Healthcare Technology Systems Generating Revenue 00000 0000000 00.0
Casma Therapeutics 10-Sep-2020 Early Stage VC 0000 Drug Discovery Generating Revenue 0000000 000 00.0
You’re viewing 10 of 87 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

The Column Group Exits (23)

Company Name Exit Date Exit Type Exit Size
Nurix 05-Mar-2021 Public Investment 2nd Offering 00000
0000 0000000000000 13-Nov-2020 000000 0000000000 00000
00000 24-Jul-2020 000 00000
0000000000000 0000 17-Jun-2020 000000 0000000000 00000
0000 0000000000000 24-Apr-2020 000 00000
0000000000 0000000 13-Feb-2020 000 00000
0000 000000000000 07-Feb-2020 000000 0000000000 0000
0000 000000000000 01-Nov-2019 000 0000
Exonics Therapeutics 16-Jul-2019 Merger/Acquisition 00000
Peloton Therapeutics 11-Jul-2019 Merger/Acquisition 00.000
You’re viewing 10 of 23 exits. Get the full list »

The Column Group Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore The Column Group‘s full profile, request access.

Request a free trial

The Column Group Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

The Column Group Team (29)

Name Title Deals Funds Boards Office
James Evangelista Chief Financial Officer San Francisco, CA
Peter Svennilson Co-Founder & Managing Partner 00 0 0 San Francisco, CA
David Goeddel Ph.D Managing Partner 00 0 0 San Francisco, CA
Robert Tjian Ph.D Discovery & Science Partner 0 0 0 San Francisco, CA
David Baltimore Ph.D Emeritus Science Partner 0 0 0 San Francisco, CA
You’re viewing 5 of 29 team members. Get the full list »

The Column Group Co-Investors (118)

Name With Exits Lead Partner Series Industry
Casdin Capital 7 0 0 Series chart Industry bar
EcoR1 Capital 0 0 0 Series chart Industry bar
Foresite Capital Management 0 0 0 Series chart Industry bar
GV 0 0 Series chart Industry bar
Lux Capital Management 0 0 Series chart Industry bar
You’re viewing 5 of 118 co-investors. Get the full list »